TVTX — Travere Therapeutics Inc

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Travere Therapeutics Inc

Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States. The company's products include FILSPARI (sparsentan), a once-daily, oral medication designed to target two critical pathways in the disease progression of IgA Nephropathy (endothelin 1 and angiotensin-II); and Thiola and Thiola EC (tiopronin tablets) for the treatment … Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$44.43
Market Cap$4.04B
Float87.1M
Shares Outstanding93.0M
P/E (Forward)57.80
Price/Sales (TTM)7.33
vs. Analyst Target+20.6% to analyst PT
Profit Margin-4.00%
Operating Margin (TTM)-29.02%
Revenue (TTM)$536M
Dividend RateNone
Analyst Target Price$53.57 (15 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $198M -$169M $192M -$145M
2021 $132M -$180M $128M -$184M
2022 $109M -$278M $105M -$299M
2023 $145M -$111M $134M -$326M
2024 $233M -$322M $225M -$266M
2025 $491M -$25.5M $480M $22.2M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 $114M -$12.8M
Sep 2025 $165M $25.7M
Dec 2025 $130M $2.7M
Mar 2026 $127M -$37.1M

Ownership & Float

Insider Ownership0.8%
Institutional Ownership114.0%
Short Float16.3%
% of All Funds Holding2.96%
Number of Funds Holding243

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$36.85Near-term / short-term trend
Weekly40-Week SMA$31.39Medium-term trend
Weekly80-Week SMA$24.61Cyclical trend (business cycle)
Weekly200-Week SMA$18.62Secular trend (multi-year)
Monthly10-Month SMA$32.73Near-term monthly trend
Monthly20-Month SMA$25.35Medium-term monthly trend
Monthly40-Month SMA$18.67Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$30.00 support 1.37x 0 months ago
$23.30 support 1.18x 6 months ago
$17.40 support 1.72x 7 months ago
$13.80 support 1.59x 18 months ago
$9.50 support 1.75x 19 months ago

Historical Earnings Reactions (53 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap -0.21% 0.12% 54.72% 16.69% -32.52%
1 Day -1.08% -0.48% 39.62% 18.58% -14.85%
1 Week -0.44% -1.13% 43.40% 18.64% -22.26%
2 Weeks -0.51% -1.67% 47.17% 33.90% -23.02%
1 Month 1.82% 3.24% 55.77% 57.86% -39.86%

Next earnings: July 23, 2026 (57 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan5.4%57.1%14
Feb6.7%57.1%14
Mar3.1%42.9%14
Apr1.6%50.0%14
May0.5%46.2%13
Jun1.6%53.8%13
Jul1.2%53.8%13
Aug5.7%53.8%13
Sep1.3%46.2%13
Oct3.7%53.8%13
Nov3.2%53.8%13
Dec9.3%57.1%14

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday 0.70% 49.3% 639
Tuesday -0.08% 46.2% 699
Wednesday 0.50% 52.0% 696
Thursday 0.04% 48.1% 682
Friday 0.08% 49.2% 683

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 114.0%

Insider Transactions — Smart Summary

Total insider ownership: 0.8%

12-Month Insider Activity Summary

Total Filings53
Net Value-$22.6M
Net Shares Change75,906
% of Float0.1%
C-Suite Filings45
Clusters Detected5

Key Insiders

NameTitleNet ValueFilingsActivity
Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER -$657,793.24 1 N/A
Cline Christopher R. CHIEF FINANCIAL OFFICER -$581,586.785 2 N/A
Inrig Jula CHIEF MEDICAL OFFICER -$569,319.749 2 N/A
Heerma Peter CHIEF COMMERCIAL OFFICER -$537,313.492 2 N/A
ROTE WILLIAM E. Chief Research Officer -$355,719 1 N/A
REED ELIZABETH E Chief Legal Officer and GC -$230,461 1 N/A
Coughlin Timothy -$141,342.5 1 N/A

Transaction Clusters

PeriodFilingsInsidersNet ValueSeniority
2025-10-30 – 2025-11-05 5 4 -$3.3M 4 C-suite
2025-12-29 – 2026-01-07 5 4 -$2.3M 5 C-suite
2026-01-21 – 2026-02-04 12 7 -$5.9M 12 C-suite
2026-04-02 – 2026-04-16 11 8 -$7.9M 8 C-suite
2026-04-23 – 2026-05-06 10 8 -$3.7M 7 C-suite

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-04-16 Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER -$657,793.24 Transaction at $28.56, now +55.6%
2026-05-19 Coughlin Timothy -$141,342.5 Transaction at $43.49, now +2.2%
2026-04-23 ROTE WILLIAM E. Chief Research Officer -$355,719 Transaction at $39.09, now +13.7%
2026-04-15 Inrig Jula CHIEF MEDICAL OFFICER -$345,893.029 Transaction at $42.01, now +5.8%
2026-04-15 Heerma Peter CHIEF COMMERCIAL OFFICER -$302,516.292 Transaction at $41.93, now +6.0%
2026-04-15 Cline Christopher R. CHIEF FINANCIAL OFFICER -$348,973.745 Transaction at $41.91, now +6.0%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Travere Therapeutics Inc (TVTX) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for TVTX on Trend Edge →